Literature DB >> 26275803

Equine herpesvirus-1 suppresses type-I interferon induction in equine endothelial cells.

Sanjay Sarkar1, Udeni B R Balasuriya2, David W Horohov2, Thomas M Chambers2.   

Abstract

Equine herpesvirus-1 (EHV-1) is one of the most common and important respiratory viral pathogens of horses. EHV-1 in horses replicates initially in the respiratory epithelium and then spreads systematically to endothelial cells lining the small blood vessels in the uterus and spinal cord, and highly pathogenic virus strains can produce aborted fetuses or myeloencephalopathy. Like other herpes viruses, EHV-1 employs a variety of mechanisms for immune evasion. Some herpes viruses down-regulate the type-I interferon (IFN) response to infection, but such activity has not been described for EHV-1. Here, in an in vitro system utilizing an established equine endothelial cell line, we studied the temporal effect on IFN-β responses following infection with the neuropathogenic T953 strain of EHV-1. Results show that after an early induction of IFN-β, the virus actively shut down further production of IFN-β and this was correlated with expression of the viral late genes. Expression of the IFN response factor viperin, a marker of host cell type-I IFN responses, was also suppressed by T953 virus infection. EHV-1-mediated suppression of host type-I IFN responses may play an important role in EHV-1 pathogenesis and the mechanism of this, presumably involving a viral late gene product, warrants investigation.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EHV-1; IFN-β; Immune evasion; Innate immunity

Mesh:

Substances:

Year:  2015        PMID: 26275803     DOI: 10.1016/j.vetimm.2015.07.015

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  8 in total

1.  Equid Herpesvirus 1 Targets the Sensitization and Induction Steps To Inhibit the Type I Interferon Response in Equine Endothelial Cells.

Authors:  Fatai S Oladunni; Sanjay Sarkar; Stephanie Reedy; Udeni B R Balasuriya; David W Horohov; Thomas M Chambers
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

2.  Equine Arteritis Virus Uses Equine CXCL16 as an Entry Receptor.

Authors:  Sanjay Sarkar; Lakshman Chelvarajan; Yun Young Go; Frank Cook; Sergey Artiushin; Shankar Mondal; Kelsi Anderson; John Eberth; Peter J Timoney; Theodore S Kalbfleisch; Ernest Bailey; Udeni B R Balasuriya
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

3.  Allelic Variation in CXCL16 Determines CD3+ T Lymphocyte Susceptibility to Equine Arteritis Virus Infection and Establishment of Long-Term Carrier State in the Stallion.

Authors:  Sanjay Sarkar; Ernest Bailey; Yun Young Go; R Frank Cook; Ted Kalbfleisch; John Eberth; R Lakshman Chelvarajan; Kathleen M Shuck; Sergey Artiushin; Peter J Timoney; Udeni B R Balasuriya
Journal:  PLoS Genet       Date:  2016-12-08       Impact factor: 5.917

4.  Equine PBMC Cytokines Profile after In Vitro α- and γ-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment.

Authors:  Erika S Hue; Eric A Richard; Christine I Fortier; Guillaume D Fortier; Romain Paillot; Rudiger Raue; Stéphane L Pronost
Journal:  Vaccines (Basel)       Date:  2017-09-19

Review 5.  A Review of Functional Motifs Utilized by Viruses.

Authors:  Haitham Sobhy
Journal:  Proteomes       Date:  2016-01-21

Review 6.  EHV-1: A Constant Threat to the Horse Industry.

Authors:  Fatai S Oladunni; David W Horohov; Thomas M Chambers
Journal:  Front Microbiol       Date:  2019-12-03       Impact factor: 5.640

7.  Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection.

Authors:  Lila M Zarski; Patty Sue D Weber; Yao Lee; Gisela Soboll Hussey
Journal:  Pathogens       Date:  2021-01-07

8.  Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense.

Authors:  Katrien C K Poelaert; Jolien Van Cleemput; Kathlyn Laval; Herman W Favoreel; Gisela Soboll Hussey; Roger K Maes; Hans J Nauwynck
Journal:  Front Cell Infect Microbiol       Date:  2018-09-12       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.